HSPG2 and pancreatic neoplasm: As shown in Figure S5B (Supporting Information), the proportion of circulating TC10, which defined as CD45+CD57−CD8+ T cells that were naïve and could predict a worse PFS in pancreas cancer patients,[15] was higher at baseline in NR patients than in R patients of PLC.